2022
A computational model for prediction of ferritin and haemoglobin levels in blood donors.
Paalvast, Y., Moazzen, S., Sweegers, M., Hogema, B., Janssen, M. and van den Hurk, K.
British Journal of Haematology 199
(1): 143-152.
October 2022
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial.
Hess, G., Hüttmann, A., Witzens-Harig, M., Dreyling, M.H., Keller, U., Marks, R., Ernst, T., Pott, C., Viardot, A., Frontzek, F., Trautmann, M., Ruckes, C., Deuster, O., Rosenwald, A., Theobald, M. and Lenz, G.
British Journal of Haematology 198
(3): 482-491.
1 April 2022
2018
Expression of CD274 (PD-L1) is associated with unfavourable recurrent mutations in AML.
Zajac, M., Zaleska, J., Dolnik, A., Bullinger, L. and Giannopoulos, K.
British Journal of Haematology 183
(5): 822-825.
December 2018
Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.
Dang, N.H., Ogura, M., Castaigne, S., Fayad, L.E., Jerkeman, M., Radford, J., Pezzutto, A., Bondarenko, I., Stewart, D.A., Shnaidman, M., Sullivan, S., Vandendries, E., Tobinai, K., Ramchandren, R., Hamlin, P.A., Giné, E. and Ando, K.
British Journal of Haematology 182
(4): 583-586.
August 2018
2017
Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras, N., Dahm, S., Haberland, J., Janz, M., Emrich, K., Kraywinkel, K. and Salama, A.
British Journal of Haematology 177
(2): 226-242.
April 2017
2015
Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease.
Kortüm, K.M., Langer, C., Monge, J., Bruins, L., Egan, J.B., Zhu, Y.X., Shi, C.X., Jedlowski, P., Schmidt, J., Ojha, J., Bullinger, L., Liebisch, P., Kull, M., Champion, M.D., Van Wier, S., Ahmann, G., Rasche, L., Knop, S., Fonseca, R., Einsele, H., Stewart, A.K. and Braggio, E.
British Journal of Haematology 168
(4): 507-510.
February 2015
2011
BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines.
Ullrich, K., Wurster, K.D., Lamprecht, B., Koechert, K., Engert, A., Doerken, B., Janz, M. and Mathas, S.
British Journal of Haematology 155
(3): 398-402.
November 2011
2007
Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis.
Lietz, A., Janz, M., Sigvardsson, M., Jundt, F., Doerken, B. and Mathas, S.
British Journal of Haematology 137
(4): 342-348.
May 2007
Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.
Westermann, J., Kopp, J., van Lessen, A., Hecker, A.C., Baskaynak, G., le Coutre, P., Doehner, K., Doehner, H., Doerken, B. and Pezzutto, A.
British Journal of Haematology 137
(4): 297-306.
May 2007
2006
Simultaneous cytokine analysis by cytometric bead array for the detection of leukaemia-reactive T cells in patients with chronic myeloid leukaemia.
Westermann, J., Lessen, A., Schlimper, C., Baskaynak, G., Coutre, P., Doerken, B. and Pezzutto, A.
British Journal of Haematology 132
: 32-35.
January 2006
2005
Empirical antimicrobial monotherapy in patients after high-dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trial.
Reich, G., Cornely, O.A., Sandherr, M., Kubin, T., Krause, S., Einsele, H., Thiel, E., Bellaire, T., Doerken, B. and Maschmeyer, G.
British Journal of Haematology 130
: 265-270.
1 July 2005
2004
T cell recognition of bcr/abl in healthy donors and in patients with chronic myeloid leukaemia.
Westermann, J., Schlimper, C., Richter, G., Mohm, J., Doerken, B. and Pezzutto, A.
British Journal of Haematology 125
(2): 213-216.
1 April 2004
Filgrastim-induced stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: safety, feasibility and evidence for an efficient in vivo purging.
Kreuzer, K.A., Kluehs, C., Baskaynak, G., Movassaghi, K., Doerken, B. and Le Coutre, P.
British Journal of Haematology 124
(2): 195-199.
1 January 2004
2002
Alveolar rhabdomyosarcoma with bone marrow infiltration mimicking haematological neoplasia.
Maywald, O., Metzgeroth, G., Schoch, C., Ludwig, W.D., Neff, W., Hehlmann, R. and Hastka, J.
British Journal of Haematology 119
: 583.
1 December 2002
2001
Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias.
Kreuzer, K.A., Saborowski, A., Lupberger, J., Appelt, C., Na, I.K., le Coutre, P. and Schmidt, C.A.
British Journal of Haematology 114
(2): 313-318.
August 2001
Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2.
Hilgenfeld, E., Padilla-Nash, H., McNeil, N., Knutsen, T., Montagna, C., Tchinda, J., Horst, J., Ludwig, W.D., Serve, H., Buechner, T., Berdel, W.E., Schroeck, E. and Ried, T.
British Journal of Haematology 113
: 305-317.
1 May 2001
Acute myeloid leukaemia MO: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients.
Bene, M.C., Bernier, M., Casasnovas, R.O., Castoldi, G., Doekharan, D., van der Holt, B., Knapp, W., Lemez, P., Ludwig, W.D., Matutes, E., Orfao, A., Schoch, C., Sperling, C. and van't Veer, M.B.
British Journal of Haematology 113
: 737-745.
1 January 2001
2000
Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
Wuchter, C., Karawajew, L., Ruppert, V., Schrappe, M., Harbott, J., Ratei, R., Doerken, B. and Ludwig, W.D.
British Journal of Haematology 110
: 154-160.
1 July 2000
1998
Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia.
Beltinger, C., Boehler, T., Karawajew, L., Ludwig, W.D., Schrappe, M. and Debatin, K.M.
British Journal of Haematology 102
: 722-728.
1 August 1998
Monitoring oral anticoagulant therapy in patients with lupus anticoagulants.
Ortel, T.L. and Moll, S.
British Journal of Haematology 101
: 390-392.
1 May 1998
Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12.
Streubel, B., Sauerland, C., Heil, G., Freund, M., Bartels, H., Lengfelder, E., Wandt, H., Ludwig, W.D., Nowotny, H., Baldus, M., Grothaus-Pinke, B., Buechner, T. and Fonatsch, C.
British Journal of Haematology 100
: 521-533.
1 March 1998
Immunophenotypic and clinical features of T-cell receptor gammadelta+ T-lineage acute lymphoblastic leukaemia.
Schott, G., Sperling, C., Schrappe, M., Ratei, R., Martin, M., Meyer, U., Riehm, H. and Ludwig, W.D.
British Journal of Haematology 101
: 753-755.
1 January 1998
1997
New insights into the biology of Philadelphia-chromosome-positive acute lymphoblastic leukaemia using a combination of May-Grunwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level.
Haferlach, T., Winkemann, M., Ramm-Petersen, L., Meeder, M., Schoch, R., Weber-Matthiesen, K., Schlegelberger, B., Schoch, C., Ludwig, W.D., Hiddemann, W. and Loffler, H.
British Journal of Haematology 99
: 452-459.
1 November 1997
Morphological and cytochemical findings in 150 cases of T-lineage acute lymphoblastic leukemia in adults.
Gassmann, W., Loeffler, H., Thiel, E., Ludwig, W.D., Schwartz, S., Haferlach, T., Maurer, J., Rieder, H., Fonatsch, C., Goekbuget, N. and Hoelzer, D.
British Journal of Haematology 97
: 372-382.
1 January 1997
Expression of intercellular adhesion molecule 1 (ICAM-1) in childhood acute lymphoblastic leukemia: correlation with clinical features and outcome.
Mielcarek, M., Sperling, C., Schrappe, M., Meyer, U., Riehm, H. and Ludwig, W.D.
British Journal of Haematology 96
: 301-307.
1 January 1997
Prognostic significance of additional chromosome abnormalities in adult patients with philadelphia chromosome positive acute lymphoblastic leukaemia.
Rieder, H., Ludwig, W.D., Gassmann, W., Maurer, J., Janssen, J.W., Gokbuget, N., Schwartz, S., Thiel, E., Loeffler, H., Bartram, C.R., Hoelzer, D. and Fonatsch, C.
British Journal of Haematology 95
: 678-691.
1 January 1997
1996
Acute myeloid and T-cell acute lymphoblastic leukaemia with aberrant antigen expression exhibit similar TCRdelta gene rearrangements.
Schmidt, C.A., Przybylski, G., Tietze, A., Oettle, H., Siegert, W. and Ludwig, W.D.
British Journal of Haematology 92
(4): 929-936.
1 January 1996
Secondary acute leukaemias with 11q23 rearrangement: clinical, cytogenetic, fish and fiction studies.
Zhao, Y.M., Poetsch, M., Weber-Matthiesen, K., Rohde, G., Winkemann, M., Haferlach, T., Gassmann, W., Ludwig, W.D., Grote, W., Loeffler, H. and Schlegelberger, B.
British Journal of Haematology 92
(3): 673-680.
1 January 1996
1995
The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event.
Janssen, J.W., Ridge, S.A., Papadopoulos, P., Cotter, F., Ludwig, W.D., Fonatsch, C., Rieder, H., Ostertag, W., Bartram, C.R. and Wiedemann, L.M.
British Journal of Haematology 90
(1): 222-224.
1 January 1995
1994
Molecular characterization of illegitimate TCRdelta gene rearrangements in acute myeloid leukaemia.
Przybylski, G., Oettle, H., Ludwig, W.D., Siegert, W. and Schmidt, C.A.
British Journal of Haematology 87
: 301-307.
1 January 1994
Detection of herpesvirus type 6 by polymerase chain reaction in blood donors: random tests and prospective longitudinal studies.
Wilborn, F., Schmidt, C.A., Zimmermann, R., Brinkmann, V., Neipel, F. and Siegert, W.
British Journal of Haematology 88
: 187-192.
1 January 1994
1993
Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases.
Foss, H.D., Herbst, H., Oelmann, E., Samol, J., Grebe, M., Blankenstein, T., Matthes, J., Qin, Z., Falini, B., Pileri, S., Diamantstein, T. and Stein, H.
British Journal of Haematology 84
(4): 627-635.
1 August 1993
CD34 expression in de novo acute myeloid leukaemia.
Sperling, C., Buechner, T., Sauerland, C., Fonatsch, C., Thiel, E. and Ludwig, W.D.
British Journal of Haematology 85
: 635-637.
1 January 1993
This list was generated on Fri Aug 16 22:00:25 2024 UTC.